NCT00065572 - Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) | Biotech Hunter

Timeline

Start Date

August 31, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

Carcinoma, Renal CellKidney Neoplasms

Interventions

DRUG

ZD6126

DRUG

Placebo

Trial Locations (16)

Research Site, Los Angeles

Research Site, Newark

Research Site, Tampa

Research Site, Chicago

Research Site, Indianapolis

Research Site, Baltimore

Research Site, St Louis

Research Site, Lebanon

Research Site, Hackensack

Research Site, Rochester

Research Site, The Bronx

Research Site, Cleveland

Research Site, Portland

Research Site, Philadelphia

Research Site, Nashville

Research Site, Salt Lake City